Developing novel therapeutics for the treatment of rare diseases.

Learn More

Diazoxide Choline Controlled-Release (DCCR)

Learn More

News

Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 15, 2020

REDWOOD CITY, Calif. , Sept. 15, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results

August 10, 2020

REDWOOD CITY, Calif. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Soleno Therapeutics Added to Russell 3000® Index

June 29, 2020

REDWOOD CITY, Calif. , June 29, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Soleno – Home